These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

548 related articles for article (PubMed ID: 15624656)

  • 41. [Primary and secondary prevention of arteriosclerosis. Risk stratification of hypertension].
    Gysan DB
    Z Kardiol; 2002 Oct; 91(10):777-85. PubMed ID: 12395218
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Relationship between antihypertensive drug therapy and cognitive function in elderly hypertensive patients with memory complaints.
    Hanon O; Pequignot R; Seux ML; Lenoir H; Bune A; Rigaud AS; Forette F; Girerd X
    J Hypertens; 2006 Oct; 24(10):2101-7. PubMed ID: 16957572
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Clinical aspects and pathogenetic mechanisms of cognitive impairment in arterial hypertension].
    Puddu GM; Zito M; D'Andrea L; Cervone C; Lamanna P; Abate G
    Minerva Cardioangiol; 1996 Jun; 44(6):285-97. PubMed ID: 8927259
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Mild cognitive impairment in symptomatic and asymptomatic cerebrovascular disease.
    Popović IM; Serić V; Demarin V
    J Neurol Sci; 2007 Jun; 257(1-2):185-93. PubMed ID: 17328916
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Clinical trials for preventing post stroke cognitive impairment.
    Ankolekar S; Geeganage C; Anderton P; Hogg C; Bath PM
    J Neurol Sci; 2010 Dec; 299(1-2):168-74. PubMed ID: 20855090
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Preventing dementia by treating hypertension and preventing stroke.
    Spence JD
    Hypertension; 2004 Jul; 44(1):20-1. PubMed ID: 15173124
    [No Abstract]   [Full Text] [Related]  

  • 47. Observational Study on Cognitive function And systolic blood pressure Reduction (OSCAR): preliminary analysis of 6-month data from > 10,000 patients and review of the literature.
    Shlyakhto E
    Curr Med Res Opin; 2007 Nov; 23 Suppl 5():S13-8. PubMed ID: 18093409
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Antihypertensive treatment and cognitive function: another tempest in a P pot?
    Semplicini A; Inverso G
    J Hypertens; 2008 Aug; 26(8):1551-2. PubMed ID: 18622230
    [No Abstract]   [Full Text] [Related]  

  • 49. A substudy protocol of the hypertension in the Very Elderly Trial assessing cognitive decline and dementia incidence (HYVET-COG) : An ongoing randomised, double-blind, placebo-controlled trial.
    Peters R; Beckett N; Nunes M; Fletcher A; Forette F; Bulpitt C
    Drugs Aging; 2006; 23(1):83-92. PubMed ID: 16492072
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Can better antihypertensive treatment prevent dementia? A question under investigation].
    Kilander L
    Lakartidningen; 1999 Dec; 96(48):5357-60. PubMed ID: 10612985
    [No Abstract]   [Full Text] [Related]  

  • 51. Neurological protection provided by candesartan: reviewing the latest study results.
    Leys D
    Curr Med Res Opin; 2003; 19(5):445-8. PubMed ID: 13678485
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [The importance of antihypertensive therapy in subclinical brain damage].
    Soucek M; Rihácek I; Frána P; Plachý M
    Vnitr Lek; 2011 Sep; 57(9):751-4. PubMed ID: 21957769
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Hypertension and stroke. A high risk duo].
    Schrader J; Kulschewski A; Lüders S;
    MMW Fortschr Med; 2001 Nov; 143 Suppl():90-4, 96-8, 100-2; quiz 103-4. PubMed ID: 11797600
    [No Abstract]   [Full Text] [Related]  

  • 54. Microvascular brain damage with aging and hypertension: pathophysiological consideration and clinical implications.
    Scuteri A; Nilsson PM; Tzourio C; Redon J; Laurent S
    J Hypertens; 2011 Aug; 29(8):1469-77. PubMed ID: 21577138
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Are antihypertensive agents protective against dementia? A review of clinical and preclinical data.
    Frishman WH
    Heart Dis; 2002; 4(6):380-6. PubMed ID: 12441015
    [TBL] [Abstract][Full Text] [Related]  

  • 56. ESH-ESC guidelines for the management of hypertension.
    Erdine S; Ari O; Zanchetti A; Cifkova R; Fagard R; Kjeldsen S; Mancia G; Poulter N; Rahn KH; Rodicio JL; Ruilope LM; Staessen J; van Zwieten P; Waeber B; Williams B
    Herz; 2006 Jun; 31(4):331-8. PubMed ID: 16810473
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Hypertension and cerebrovascular disease.
    Bansal BC; Agarwal AK; Rewari BB
    J Indian Med Assoc; 1999 Jun; 97(6):226-32. PubMed ID: 10645696
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Hypertension in the elderly].
    Plouin PF; Rossignol P; Bobrie G
    Bull Acad Natl Med; 2006; 190(4-5):793-805; discussion 806, 873-6. PubMed ID: 17195607
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Mild cognitive impairment: dementia risk factor or high-risk state for progression to dementia?
    Panza F; Capurso C; D'Introno A; Colacicco AM; Gadaleta A; Frisardi V; Santamato A; Capurso A; Solfrizzi V
    J Am Geriatr Soc; 2008 Jul; 56(7):1367-9. PubMed ID: 18774976
    [No Abstract]   [Full Text] [Related]  

  • 60. Potential mechanisms of stroke benefit favoring losartan in the Losartan Intervention For Endpoint reduction in hypertension (LIFE) study.
    Devereux RB; Dahlöf B
    Curr Med Res Opin; 2007 Feb; 23(2):443-57. PubMed ID: 17288698
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 28.